• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Ultrasound sales turn up for Acuson

Article

Acuson last week downplayedan improvement in its ultrasound sales and net income for thefirst quarter of 1994 (end April 2). However, the results weregood news for the vendor and an ultrasound industry battered bydeclining U.S. purchasing. Net sales

Acuson last week downplayedan improvement in its ultrasound sales and net income for thefirst quarter of 1994 (end April 2). However, the results weregood news for the vendor and an ultrasound industry battered bydeclining U.S. purchasing.

Net sales for the first quarter rose 12% from $82.3 millionin 1993 to $92.8 million this year. Net income shot up a strong31% from $5 million in the first quarter of last year to $6.6million in the same period this year.

"Our first quarter financial results may not be indicativeof the results for the entire year," said Samuel H. Maslak,president and CEO. "Market uncertainties regarding the purchaseof hospital medical equipment will persist for an indeterminateperiod, due to ongoing worldwide medical cost containment pressuresand concern about the potential impacts of U.S. health-care reform."

Acuson may be right in downplaying a possible market upturn.Ultrasound competitor ATL saw revenue drop 6% for the same three-monthperiod, from $81.4 million in 1993 to $75.9 million this year.

"We expect the difficult market conditions in the U.S.to continue for the near term," said Dennis C. Fill, chairmanand CEO.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.